The company operates out of Columbus, Ohio
Although most people tolerate semaglutide, there are some common side effects such as nausea, diarrhea, constipation, headache and dizziness
David Smith, urologist and co-founder of medical device company BladGo Medical, told Drugwatch
On average, studies indicate that patients can shed between 5-10% of their body weight
In their paper on the study, published in JAMA Ophthalmology , the researchers noted that the substantially increased risk of NAION observed in patients on semaglutide appears not to be due to differences in baseline characteristics between the cohorts. They proposed the possibility that expression of the GLP-1 receptor in the human optic nerve and GLP-1 RA-induced enhanced sympathetic nervous system activity might influence optic nerve head perfusion and potentially increase the risk of NAION. Another notable finding was that the greatest risk of NAION appeared to be within the first year following the prescription of semaglutide, a temporal association that supports a potential drug-induced risk of NAION, the researchers pointed out
Florida doctors say patients think they can use drugs like Wegovy to lose some weight and then stop taking them
